Clinical Research Directory
Browse clinical research sites, groups, and studies.
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Sponsor: Friends Research Institute, Inc.
Summary
This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
320
Start Date
2022-07-01
Completion Date
2026-12-30
Last Updated
2026-11-12
Healthy Volunteers
Yes
Conditions
Interventions
Buprenorphine/Naloxone
Participants will begin buprenorphine pharmacotherapy using the MedicaSafe buprenorphine dispensing device immediately after an on-site intake at a community supervision office and continue such treatment until they are transitioned to community buprenorphine treatment
Treatment as usual
Participants will receive a referral to buprenorphine treatment in the community
Locations (1)
Division of Parole & Probation
Baltimore, Maryland, United States